The global urinary drainage bags market is expected to exhibit a solid 6.8% CAGR over the forecast period from 2019 to 2024, according to the latest research report from Market Research Future (MRFR). The global urinary drainage bags market was valued at USD 142.54 million in 2018, according to the MRFR report.
The market's historical growth trajectory, present conditions, and future growth prospects are studied in the report. The report provides a comprehensive overview of the market's historical growth trajectory by detailing the historical stats regarding the market. Future projections are based on the detailed historical stats offered in the report.
Urinary drainage bags are used to collect urine from patients who have lost control of their bladder due to some issue. Urinary incontinence is the primary cause for using urinary drainage bags.
Competitive Leaderboard:
Leading players in the global urinary drainage bags market include Amsino International Inc., Coloplast, Cook Medical, C. R. Bard Inc., Medline Industries Inc., Moore Medical LLC, Pacific Hospital Supply Co. Ltd., Covidien, Flexicare Medical Limited, Plasti-med, and Teleflex Inc.
Regional Analysis:
The Americas are anticipated to dominate the global urinary drainage bags market over the forecast period due to the high number of patients in the region and the widespread awareness about various types of incontinence and the awareness among patients to come forward and seek a resolution for urinary incontinence. The high healthcare expenditure in North America and the strong presence of major players in the region are also leading drivers for the urinary drainage bags market in North America.
Europe is expected to hold the second largest share in the global urinary drainage bags market, followed by Asia Pacific.
The rising demand for ambulatory infusion pumps in home care settings, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, and growing number of surgical procedures performed are the major factors driving the growth of this market.The global Infusion Pump Market is projected to reach USD 18.9 billion by 2025 from USD 13.5 billion in 2020, at a CAGR of 7.0% during the forecast period.Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506 Market Segmentation:-Based on products, the Infusion Pumps Accessories Market is segmented into accessories & consumables and devices.
The accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.Based on product, the infusion pumps market is segmented into dedicated accessories & consumables and non-dedicated accessories & consumables.
The dedicated accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.Based on type, the Infusion Pumps Accessories Market has been segmented into traditional infusion pumps and specialty infusion pumps market.
The specialty infusion pumps segment is expected to grow at the highest CAGR during the forecast period.Based on application, the Infusion Pumps Accessories Market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver).On the basis of end user, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic and research institutes.Key Market Drivers: - 1 Rising demand for ambulatory infusion pumps in home care settings 2 Increasing incidence of chronic diseases along with the rapid growth of the geriatric population 3 Growing numbers of surgical procedures performedRegional Analysis:-North America accounted for the largest share of the infusion pumps market in 2019, followed by Europe.Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=90374506Key market Players:-The prominent players in this market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), ICU Medical, Inc. (US), Medtronic plc (Ireland), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), and Ypsomed Holding AG (Switzerland), among other key players.
The Cell Surface Markers Market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, growing at a CAGR of 8.1% during the forecast period.The growth of this market is driven by factors such as the high global prevalence of cancer, growth in stem cell and neurobiology research, and the increasing funding for life sciences research.Clinical Applications Segment is Expected to Grow at the Highest CAGR During the Forecast PeriodBased on application, the cell surface markers market is segmented into research applications and clinical applications.
The clinical applications segment is expected to witness higher growth during the forecast period primarily due to the rising prevalence of cancer and the increasing adoption of cell surface markers in cancer treatment.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216278622Hospitals & Clinical Testing Laboratories use Cell Surface Markers for the Diagnosis of Various Diseases On the basis of end user, the cell surface markers market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies.
The hospitals & clinical testing laboratories segment is expected to register the highest CAGR during the forecast period.North America is expected to be the largest regional market for cell surface markers in 2018 The global cell surface markers market is segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World.
In 2018, North America is expected to account for the largest share of the market.
The large share of the North American market is attributed to factors such as the increasing number of R activities and the growing use of cell surface markers in personalized medicine and drug discovery & development.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=216278622Leading PlayersThermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Merck KGaA (Germany), and Bio-Techne (US)
The global engineered wood market is projected to grow at a CAGR of 12.82% during the forecast period.
As per the engineered wood market research report, the global market for engineered wood is projected to grow swiftly by US$24.12 million by 2023.
According to analysts, scarcity of wood products as well as government norms and regulations will drive the market growth during the forecast period.
The engineered wood market research report by expert analysts is developed to assist organizations in the engineered wood market.Get Free Sample PDF @ https://www.marketresearchfuture.com/sample_request/4791Market SegmentationThe global engineered wood market has been segmented into product types and applications.
By product type, the global market has been segmented into plywood, laminated veneer lumber (LVL), glulam, I-beams, and cross laminated timber (CLT).By application, the global engineered wood market has been segmented into residential and non-residential.
This market has increased rapidly in the past decade despite the economic downturn.
Attractive market opportunities in the autoimmune disease diagnosis market 2.
Growth in the number of reagent rental agreements The global autoimmune disease diagnosis market size is expected to grow from USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%.
Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Autoimmune Disease Diagnosis market?
What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519 Autoimmune Disease Diagnosis Consumables & Assay Kits: Based on the product, the autoimmune disease diagnosis industry is segmented into consumables & assay kits and instruments.
The consumables & assay kits segment is expected to grow at the highest growth rate during the forecast period.
According to the new market research report Spatial Genomics Market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551The market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical RSpatial Transcriptomics techniques accounted for the largest share of the spatial genomics marketBased on the technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques.
In 2019, the spatial transcriptomics techniques segment accounted for the largest share of the global spatial genomics market.
Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.Academic & Research Institutes is the fastest-growing end-user segment of the marketBased on end-users, the spatial genomics market is segmented into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies.
In 2019, the academic & research institutes segment accounted for the largest share of the transcriptomics market.
Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.North America accounted for the largest share of the spatial genomics marketNorth America held the largest share in the global market, followed by Europe, with a share of 21.6%.
The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics market in this region.10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the transcriptomics market.
Research Report Insights (RRI) delivers key insights on the global High pressure processing equipment market in its latest report titled, “High Pressure Processing Equipment Market by 2026”.
The report projects the market size on the virtue of adoption of high pressure processing equipment for cold pasteurization in global food and beverages industry.
According to the report, the global high pressure processing equipment market is projected to expand with an estimated CAGR of 12.3% in terms of volume, over the forecast period.
Among applications based segments, juices & beverages segment is anticipated to register relatively higher CAGR in terms of value over the forecast period.
Global sales of high pressure processing equipment was valued at US$ 133.5 Mn by the end of 2016, and is expected to create an incremental dollar opportunity of US$ 350.5 Mn during the forecast period.
Request For Report Sample: https://www.researchreportinsights.com/report/sample/110114822/High-Pressure-Processing-Equipment-Market Changing life style and eating habits have resulted in significant increase in demand for processed, packaged food products and ready-to-eat food across the globe.